Chemical Biology & Drug Design · 2009 · 122 citations · 17 references
MedicineMedicinal ChemistryPharmacologyNeuropharmacologyPsychopharmacologyStructure-activity RelationshipsAntiepileptic PharmacologyDrug-induced NeurotoxicityAnticonvulsant ActionAnticonvulsant DrugsAnticonvulsant NeurotoxicityAnticonvulsant PharmacologyAnticonvulsant TreatmentEffective Concentration MedianMedian Effective Dose
A new series of 6-alkoxy-[1,2,4]triazolo[3,4-a]phthalazines (3a-3v) were synthesized and their anticonvulsant activity and neurotoxicity were evaluated by the maximal electroshock test and the rotarod test respectively. Significant anticonvulsant activity was displayed by a number of compounds. The most promising compounds 6-(4-chlorobenzyloxy)-[1,2,4]triazolo[3,4-a]phthalazine (3f) and 6-heptyloxy-[1,2,4]triazolo[3,4-a]phthalazine (3s) showed a median effective dose of 7.1 and 11.0 mg/kg, and had protective index value of 5.2 and 8.0 respectively. The two compounds were further found to have potent activity against seizures induced by pentylenetetrazole, isoniazid, thiosemicarbazide, 3-mercaptopropionic acid but not seizures induced by strychnine, indicating that the two compounds might function by enhancing gamma-aminobutyric acid neurotransmission.
17
Antiepileptic Drug Development: II. Anticonvulsant Drug Screening
Ronald L Krall, J. K. Penry, B. G. White et al. · Epilepsia · 1978 · 823 citations
Antiepileptic Drug Development Program
Roger J. Porter, James J. Cereghino, G. D. Gladding et al. · Cleveland Clinic Journal of Medicine · 1984 · 492 citations
Robert W. Carling, Kevin W. Moore, Leslie J. Street et al. · Journal of Medicinal Chemistry · 2004 · 135 citations · Full text